Bio Green Med Solution (BGMS) Liabilities from Discontinued Operations (2011 - 2016)
Bio Green Med Solution (BGMS) posted quarterly Liabilities from Discontinued Operations of 29000.0 for Q3 2016, down 61.33% year-over-year from 75000.0 in Q4 2015, and down 61.33% quarter-over-quarter from 75000.0 in Q2 2016.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Liabilities from Discontinued Operations (2011 - 2016) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Liabilities from Discontinued Operations for 6 consecutive years, with 29000.0 the latest figure, recorded in Q3 2016.
- In Q3 2016, Liabilities from Discontinued Operations fell 61.33% year-over-year to 29000.0; the TTM figure through Sep 2016 stood at 29000.0 (down 61.33% YoY), while the FY2015 annual figure was 75000.0, changed 0.0% from the prior year.
- Liabilities from Discontinued Operations eased to 29000.0 in Q3 2016 per BGMS's latest filing, from 75000.0 in the prior quarter.
- Across five years, Liabilities from Discontinued Operations topped out at 438000.0 in Q3 2012 and bottomed at 29000.0 in Q3 2016.
- Historically, Liabilities from Discontinued Operations has averaged 178647.06 across 5 years, with a median of 75000.0 in 2014.
- Annual changes were most pronounced in 2014 — Liabilities from Discontinued Operations plunged 76.71% — and 2015, when it changed 0.0%.
- Bio Green Med Solution's Liabilities from Discontinued Operations stood at 335000.0 in 2012, then dropped by 22.39% to 260000.0 in 2013, then slumped by 71.15% to 75000.0 in 2014, then changed by 0.0% to 75000.0 in 2015, then slumped by 61.33% to 29000.0 in 2016.
- Business Quant data shows BGMS's Liabilities from Discontinued Operations at 29000.0 in Q3 2016, 75000.0 in Q2 2016, and 75000.0 in Q1 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.60 Bn | 132.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 87.04 Bn | 79.04 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn |
| 4 | Moderna | 58.38 Bn | 53.25 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.27 Bn | 44.27 Bn | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.21 Bn | 31.90 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.01 Bn | 27.17 Bn | - |
| 9 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 5.04 Mn | 1.25 Mn | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2016 | 29,000.00 |
| Jun 30, 2016 | 75,000.00 |
| Mar 31, 2016 | 75,000.00 |
| Dec 31, 2015 | 75,000.00 |
| Sep 30, 2015 | 75,000.00 |
| Jun 30, 2015 | 75,000.00 |
| Mar 31, 2015 | 75,000.00 |
| Dec 31, 2014 | 75,000.00 |
| Sep 30, 2014 | 75,000.00 |
| Jun 30, 2014 | 145,000.00 |
| Mar 31, 2014 | 260,000.00 |
| Dec 31, 2013 | 260,000.00 |
| Sep 30, 2013 | 322,000.00 |
| Jun 30, 2013 | 325,000.00 |
| Mar 31, 2013 | 323,000.00 |
| Dec 31, 2012 | 335,000.00 |
| Sep 30, 2012 | 438,000.00 |
| Dec 31, 2011 | 527,000.00 |